Core A: Administration

核心A:管理

基本信息

  • 批准号:
    10264527
  • 负责人:
  • 金额:
    $ 11.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2021-08-31
  • 项目状态:
    已结题

项目摘要

The overall goal of the Administrative Shared Resource for the Iowa Neuroendocrine Tumor SPORE (INET SPORE) is to stimulate multi-disciplinary research in neuroendocrine tumors (NETs) and to translate these observations and discoveries into personalized medicine for early detection of, curative treatments for, and ultimately, the prevention of neuroendocrine tumors in adults and children. The Administration Core is designed to serve as the organizational hub for the benefit of investigators, core directors, career and developmental project awardees, and external investigators who seek to further our overall goals. The Administrative Core will therefore provide an organizational structure designed to coordinate the activities of the research projects, scientific cores, and developmental programs (Developmental Research Program, Career Development Program) and will be responsible for coordinating the function of the SPORE committees including the Executive Committee, the Internal Advisory Committee, and the External Advisory Committee. M Sue O'Dorisio, MD, PhD, will serve as Director of the Administration Core, with James Howe, MD as Co- Director. These senior investigators will now extend their collaborations to provide leadership and oversight of SPORE activities in the following ways: 1) provide leadership, organizational support, and financial management to SPORE core directors and to investigators for both major and developmental projects; 2) work with the Executive Committee to provide continual scientific review to select and support the most promising full projects and developmental projects in accordance with SPORE guidelines; 3) foster career development for investigators dedicated to basic and clinical research in neuroendocrine tumors; 4) provide oversight of SPORE Cores to ensure continual quality improvement in services for investigators; 5) coordinate monthly investigator meetings, quarterly progress reviews by the internal review committee, and a yearly review by the External review committee; 6) work with investigators and patient advocates to build new internal and external collaborations that will expand access to comprehensive, state-of-the-art care for patients with neuroendocrine tumors; 7) disseminate new information from SPORE investigations to professionals and patient organizations who care for patients with neuroendocrine tumors, as well as to the scientific community and the public; 8) maintain timely communications with the National Cancer Institute. 9) Continually improve the overall Program Organization and Capabilities through excellent communication and collaboration with the Holden Comprehensive Cancer Center (HCCC), the Iowa Institute for Clinical & Translational Sciences (ICTS), and the Colleges of Medicine, Engineering, and Public Health
爱荷华州神经内分泌肿瘤孢子(INET)管理共享资源的总体目标 SPORE)旨在促进神经内分泌肿瘤(NET)的多学科研究,并将这些研究成果转化为 观察和发现到个性化的医疗,早期发现,治愈性治疗, 最终,预防成人和儿童的神经内分泌肿瘤。行政核心是 旨在作为组织中心,为调查员、核心主任、职业和 发展项目获奖者,以及寻求进一步实现我们总体目标的外部调查人员。的 因此,行政核心将提供一个组织结构,以协调 研究项目、科学核心和发展计划(发展研究计划, 职业发展计划),并将负责协调SPORE委员会的职能 包括执行委员会、内部咨询委员会和外部咨询委员会。M Sue O 'Dorisio,医学博士,博士,将担任行政核心主任,James Howe,医学博士担任共同主任。 导演这些高级调查员现在将扩大他们的合作,以提供领导和监督, 以下列方式开展SPORE活动: 1)为SPORE核心董事提供领导、组织支持和财务管理, 主要项目和发展项目的调查员; 2)与执行委员会合作,提供持续的科学审查,以选择和支持最 根据SPORE指导方针,承诺全面项目和发展项目; 3)促进致力于神经内分泌基础和临床研究的研究人员的职业发展 肿瘤; 4)对SPORE核心进行监督,以确保服务质量的持续改进, 调查员; 5)协调每月的调查员会议,内部审查委员会的季度进展审查, 以及外部审查委员会的年度审查; 6)与研究人员和患者倡导者合作,建立新的内部和外部合作, 扩大神经内分泌肿瘤患者获得全面、最先进护理的机会; 7)向专业人员和患者组织传播来自SPORE调查的新信息 照顾神经内分泌肿瘤患者的人,以及科学界和 公共的; 8)与国家癌症研究所保持及时沟通。 9)通过卓越的管理,不断提高整体项目组织和能力 与霍尔顿综合癌症中心(HCCC)、爱荷华州 临床与转化科学研究所(ICTS),以及医学,工程和 公共卫生

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

M. Sue O'Dorisio其他文献

M. Sue O'Dorisio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('M. Sue O'Dorisio', 18)}}的其他基金

Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
人类癌症神经内分泌肿瘤卓越研究专门计划 (SPORE)
  • 批准号:
    10264523
  • 财政年份:
    2015
  • 资助金额:
    $ 11.24万
  • 项目类别:
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
人类癌症神经内分泌肿瘤卓越研究专门计划 (SPORE)
  • 批准号:
    9342676
  • 财政年份:
    2015
  • 资助金额:
    $ 11.24万
  • 项目类别:
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
人类癌症神经内分泌肿瘤卓越研究专门计划 (SPORE)
  • 批准号:
    8850619
  • 财政年份:
    2015
  • 资助金额:
    $ 11.24万
  • 项目类别:
Core A: Administration
核心A:管理
  • 批准号:
    8850624
  • 财政年份:
    2015
  • 资助金额:
    $ 11.24万
  • 项目类别:
Admin-Core-001
管理核心-001
  • 批准号:
    10025356
  • 财政年份:
    2015
  • 资助金额:
    $ 11.24万
  • 项目类别:
Dosimetry Guided Phase II of 90Y-DOTA-tyr3-Octreotide + Retinoic Acid in Kids
90Y-DOTA-tyr3-奥曲肽视黄酸儿童剂量测定指导 II 期试验
  • 批准号:
    7749337
  • 财政年份:
    2009
  • 资助金额:
    $ 11.24万
  • 项目类别:
90Y-DOTA-TYR3-OCTREOTIDE ADMINISTERED TO CHILDREN WITH REFRACTORY TUMORS
90Y-DOTA-TYR3-奥曲肽治疗难治性肿瘤儿童
  • 批准号:
    7604807
  • 财政年份:
    2007
  • 资助金额:
    $ 11.24万
  • 项目类别:
CPTK787/ZK222584 IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS
CPTK787/ZK222584 在转移性神经内分泌肿瘤患者中的应用
  • 批准号:
    7604868
  • 财政年份:
    2007
  • 资助金额:
    $ 11.24万
  • 项目类别:
CPTK787/ZK222584 IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS
CPTK787/ZK222584 在转移性神经内分泌肿瘤患者中的应用
  • 批准号:
    7377088
  • 财政年份:
    2006
  • 资助金额:
    $ 11.24万
  • 项目类别:
90Y-DOTA-TYR3-OCTREOTIDE ADMINISTERED TO CHILDREN WITH REFRACTORY TUMORS
90Y-DOTA-TYR3-奥曲肽治疗难治性肿瘤儿童
  • 批准号:
    7376989
  • 财政年份:
    2006
  • 资助金额:
    $ 11.24万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 11.24万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 11.24万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 11.24万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 11.24万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 11.24万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 11.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了